4//SEC Filing
Stuart Bryan 4
Accession 0000899243-22-002879
CIK 0001680581other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:15 PM ET
Size
5.5 KB
Accession
0000899243-22-002879
Insider Transaction Report
Form 4
Stuart Bryan
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-19+340,000→ 340,000 totalExercise: $12.69Exp: 2032-01-18→ Common Stock (340,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 19, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001619846
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:15 PM ET
- Size
- 5.5 KB